Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission

被引:23
作者
Chi, BH
Mudenda, V
Levy, J
Sinkala, M
Goldenberg, RL
Stringer, JSA
机构
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] Univ Zambia, Sch Med, Lusaka, Zambia
[3] Ctr Infect Dis Res Zambia, Lusaka, Zambia
[4] Univ Teaching Hosp, Lusaka, Zambia
关键词
chorioamnionitis; interleukin-6; human immunodeficiency virus-1; perinatal human immunodeficiency virus-1 transmission; mother-to-child human immunodeficiency virus-1 transmission;
D O I
10.1016/j.ajog.2005.06.081
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study was undertaken to examine the prevalence of acute and chronic chorioamnionitis among women infected with human immunodeficiency virus-1 (HIV-1) and to determine the relative contribution of each to perinatal HIV-1 transmission. Study design: In 227 HIV-infected women receiving intrapartum/neonatal nevirapine prophylaxis, we examined associations between fetal membrane histology, cord blood interleukin-6 (IL-6), and perinatal HIV-1 transmission. Results: Acute chorioamnionitis was present in 122 of 227 specimens; chronic chorioamnionitis in 64 of 227. There was a positive correlation between acute chorioamnionitis and labor length (r = 0.208; P= .002), time of ruptured membrane (r = 0.177; P = .008), and cord IL-6 (r = 0.390; P <.001). Chronic chorioamnionitis was associated with high viral load (P =.05) and low cord IL-6 (P <.001). Severe chronic chorioamnionitis was associated with intrauterine HIV-1 transmission (odds ratio [OR] = 7.61; 95% Cl = 1.04-85.5), but no correlation was demonstrated between acute chorioamnionitis and vertical transmission. Conclusion: In a setting of high perinatal nevirapine use, acute chorioamnionitis was not associated with vertical HIV-1 transmission. Risk for intrauterine transmission increased significantly when chronic chorioamnionitis was present. (c) 2006 Mosby, Inc. All rights reserved.
引用
收藏
页码:174 / 181
页数:8
相关论文
共 32 条
[21]   COMPARISON OF CD4 CELL COUNT BY A SIMPLE ENZYME-LINKED-IMMUNOSORBENT-ASSAY USING THE TRAX CD4 TEST KIT AND BY FLOW-CYTOMETRY AND HEMATOLOGY [J].
PAXTON, H ;
PINS, M ;
DENTON, G ;
MCGONIGLE, AD ;
MEISNER, PS ;
PHAIR, JP .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (01) :104-114
[22]   The relationship between placental and other perinatal risk factors for neurologic impairment in very low birth weight children [J].
Redline, RW ;
Wilson-Costello, D ;
Borawski, E ;
Fanaroff, AA ;
Hack, M .
PEDIATRIC RESEARCH, 2000, 47 (06) :721-726
[23]   The Maternal-Fetal Medicine Units cesarean registry: Chorioamnionitis at term and its duration-relationship to outcomes [J].
Rouse, DJ ;
Landon, M ;
Leveno, KJ ;
Leindecker, S ;
Varner, MW ;
Caritis, SN ;
O'Sullivan, MJ ;
Wapner, RJ ;
Meis, PJ ;
Miodovnik, M ;
Sorokin, Y ;
Moawad, AH ;
Mabie, W ;
Conway, D ;
Gabbe, SG ;
Spong, CY .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (01) :211-216
[24]   Fetal but not maternal serum cytokine levels correlate with histologic acute placental inflammation [J].
Salafia, CM ;
Sherer, DM ;
Spong, CY ;
Lencki, S ;
Eglinton, GS ;
Parkash, V ;
Marley, E ;
Lage, JM .
AMERICAN JOURNAL OF PERINATOLOGY, 1997, 14 (07) :419-422
[25]   RISK FOR PERINATAL HIV-1 TRANSMISSION ACCORDING TO MATERNAL IMMUNOLOGICAL, VIROLOGICAL, AND PLACENTAL FACTORS [J].
STLOUIS, ME ;
KAMENGA, M ;
BROWN, C ;
NELSON, AM ;
MANZILA, T ;
BATTER, V ;
BEHETS, F ;
KABAGABO, U ;
RYDER, RW ;
OXTOBY, M ;
QUINN, TC ;
HEYWARD, WL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (22) :2853-2859
[26]   Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings [J].
Stringer, JSA ;
Sinkala, M ;
Goldenberg, RL ;
Kumwenda, R ;
Acosta, EP ;
Aldrovandi, GM ;
Stout, JP ;
Vermund, SH .
AIDS, 2004, 18 (06) :939-943
[27]   Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine [J].
Stringer, JSA ;
Sinkala, M ;
Chapman, V ;
Acosta, EP ;
Aldrovandi, GM ;
Mudenda, V ;
Stout, JP ;
Goldenberg, RL ;
Kumwenda, R ;
Vermund, SH .
AIDS, 2003, 17 (11) :1659-1665
[28]   Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings [J].
Stringer, JSA ;
Sinkala, M ;
Stout, JP ;
Goldenberg, RL ;
Acosta, EP ;
Chapman, V ;
Kumwenda-Phiri, R ;
Vermund, SH .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (05) :506-513
[29]  
Stringer JSA, 2000, ANN NY ACAD SCI, V918, P77
[30]   The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy [J].
Van Dyke, RB ;
Korber, BT ;
Popek, E ;
Macken, C ;
Widmayer, SM ;
Bardeguez, A ;
Hanson, IC ;
Wiznia, A ;
Luzuriaga, K ;
Viscarello, RR ;
Wolinsky, S .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (02) :319-328